Optura secured $17.5 million for its return on AI investment platform, and Urologic Health garnered $11 million in seed funding. 9amHealth , a virtual specialty care platform for cardiometabolic health, announced $26 million in Series B funding. Define Ventures led the round, with new participation from SemperVirens, Catalio Capital Management and NewHealth Ventures. Lynne O'Keefe, Define Ventures' founder and managing partner, will join the company's board of directors. The funds will be used to support the company's growth and enhance its platform. Optura, an enterprise platform focused on return on AI investment, scored $17.5 million in Series A funding, bringing…
9amHealth, a virtual specialty care platform for cardiometabolic health, announced $26 million in Series B funding.
Define Ventures led the round, with new participation from SemperVirens, Catalio Capital Management and NewHealth Ventures.
Lynne O'Keefe, Define Ventures' founder and managing partner, will join the company's board of directors.
The funds will be used to support the company's growth and enhance its platform.